Phase 1 Carcinoma, Non-Small-Cell Lung trials recruiting now
All Carcinoma, Non-Small-Cell Lung trials, every phase
16
Phase 1 recruiting
Other phases for Carcinoma, Non-Small-Cell Lung
Phase 1 Carcinoma, Non-Small-Cell Lung trials
- A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers
- A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
- A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants
- A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
- A Study of DM005 in Patients With Advanced Solid Tumors
- A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- A Study of LY4175408 in Participants With Advanced Cancer
- A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer
- Intratumoral N17350 in Advanced Solid Tumors
- KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.